Correlation Between Suzhou Novoprotein and Shanghai Rightongene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Shanghai Rightongene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Shanghai Rightongene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Shanghai Rightongene Biotechnology, you can compare the effects of market volatilities on Suzhou Novoprotein and Shanghai Rightongene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Shanghai Rightongene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Shanghai Rightongene.

Diversification Opportunities for Suzhou Novoprotein and Shanghai Rightongene

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Suzhou and Shanghai is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Shanghai Rightongene Biotechno in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanghai Rightongene and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Shanghai Rightongene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanghai Rightongene has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Shanghai Rightongene go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Shanghai Rightongene

Assuming the 90 days trading horizon Suzhou Novoprotein is expected to generate 2.09 times less return on investment than Shanghai Rightongene. But when comparing it to its historical volatility, Suzhou Novoprotein Scientific is 1.53 times less risky than Shanghai Rightongene. It trades about 0.11 of its potential returns per unit of risk. Shanghai Rightongene Biotechnology is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  1,452  in Shanghai Rightongene Biotechnology on September 3, 2024 and sell it today you would earn a total of  637.00  from holding Shanghai Rightongene Biotechnology or generate 43.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Suzhou Novoprotein Scientific  vs.  Shanghai Rightongene Biotechno

 Performance 
       Timeline  
Suzhou Novoprotein 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Suzhou Novoprotein Scientific are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Suzhou Novoprotein sustained solid returns over the last few months and may actually be approaching a breakup point.
Shanghai Rightongene 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Rightongene Biotechnology are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Rightongene sustained solid returns over the last few months and may actually be approaching a breakup point.

Suzhou Novoprotein and Shanghai Rightongene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Suzhou Novoprotein and Shanghai Rightongene

The main advantage of trading using opposite Suzhou Novoprotein and Shanghai Rightongene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Shanghai Rightongene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Rightongene will offset losses from the drop in Shanghai Rightongene's long position.
The idea behind Suzhou Novoprotein Scientific and Shanghai Rightongene Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stocks Directory
Find actively traded stocks across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data